FindTrial
Sign In

The efficacy and safety of Intralesional Diprospan injection and Oral Propranolol for Infantile Hemagioma on the lip: A prospective study.

The efficacy and safety of Intralesional Diprospan injection and Oral Propranolol for Infantile Hemagioma on the lip: A prospective study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17014081
Enrollment
Unknown
Registered
2017-12-21
Start date
2017-12-31
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infantile Hemangioma

Interventions

Intralesional Injection Group:Intralesional Injection
Propranolol Group:Propranolol

Sponsors

Shanghai Ninth People's Hospital, Shanghai Jiaotong University School Of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: 1. Patients who were diagnosed with Infantile Hemangioma according to ISSVA diagnostic criteria; 2. Elevated Infantile Hemangioma on the lip, with a thickness greater than 3mm, lesser than 2cm, and diameter smaller than 3cm; 3. Aged under 1 year old; 4. Untreated lesion; 5. Willing to cooperate with treatment.

Exclusion criteria

Exclusion criteria: 1. Those who have received vaccination within a week prior to visit; 2. Those with immune deficiency and cannot be exposed to corticosteroids; 3. Patients with lesion ulceration history; 4. Patients who were unwilling to cooperate with treatment.

Design outcomes

Primary

MeasureTime frame
Ultrasound;—

Countries

China

Contacts

Public ContactChang Shih-Jen

Shanghai Ninth People's Hospital, Shanghai Jiaotong University School Of Medicine

changshihjen@sjtu.edu.cn+86 18501734513

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026